IL137453A - Utilization of powder preparations containing hydroxypyridones for the production of a medicament for the treatment of leg ulcers and decubitus ulcers - Google Patents

Utilization of powder preparations containing hydroxypyridones for the production of a medicament for the treatment of leg ulcers and decubitus ulcers

Info

Publication number
IL137453A
IL137453A IL13745399A IL13745399A IL137453A IL 137453 A IL137453 A IL 137453A IL 13745399 A IL13745399 A IL 13745399A IL 13745399 A IL13745399 A IL 13745399A IL 137453 A IL137453 A IL 137453A
Authority
IL
Israel
Prior art keywords
ulcers
hydroxypyridones
medicament
utilization
treatment
Prior art date
Application number
IL13745399A
Other languages
English (en)
Other versions
IL137453A0 (en
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of IL137453A0 publication Critical patent/IL137453A0/xx
Publication of IL137453A publication Critical patent/IL137453A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL13745399A 1998-01-24 1999-01-11 Utilization of powder preparations containing hydroxypyridones for the production of a medicament for the treatment of leg ulcers and decubitus ulcers IL137453A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19802708A DE19802708A1 (de) 1998-01-24 1998-01-24 Verwendung von hydroxypyridon-haltigen Puderzubereitungen zur Behandlung von Unterschenkel- und Druckgeschwüren
PCT/EP1999/000105 WO1999037300A1 (de) 1998-01-24 1999-01-11 Verwendung von hydroxypyridon-haltigen puderzubereitungen zur behandlung von unterschenkel- und druckgeschwüren

Publications (2)

Publication Number Publication Date
IL137453A0 IL137453A0 (en) 2001-07-24
IL137453A true IL137453A (en) 2005-11-20

Family

ID=7855595

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13745399A IL137453A (en) 1998-01-24 1999-01-11 Utilization of powder preparations containing hydroxypyridones for the production of a medicament for the treatment of leg ulcers and decubitus ulcers

Country Status (27)

Country Link
US (1) US6534528B1 (pl)
EP (1) EP1049468B1 (pl)
JP (1) JP5127091B2 (pl)
KR (1) KR100597332B1 (pl)
CN (1) CN1128619C (pl)
AR (1) AR016445A1 (pl)
AT (1) ATE360418T1 (pl)
AU (1) AU752406B2 (pl)
BR (1) BR9907734A (pl)
CA (1) CA2319359C (pl)
CY (1) CY1106684T1 (pl)
DE (2) DE19802708A1 (pl)
DK (1) DK1049468T3 (pl)
ES (1) ES2285829T3 (pl)
HR (1) HRP20000496A2 (pl)
HU (1) HU228824B1 (pl)
IL (1) IL137453A (pl)
ME (1) ME00390B (pl)
NZ (1) NZ505898A (pl)
PL (1) PL192550B1 (pl)
PT (1) PT1049468E (pl)
RS (1) RS50903B (pl)
RU (1) RU2212239C2 (pl)
SI (1) SI1049468T1 (pl)
SK (1) SK285350B6 (pl)
TR (1) TR200002118T2 (pl)
WO (1) WO1999037300A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001122804A (ja) * 1999-10-28 2001-05-08 Sato Pharmaceutical Co Ltd リン酸コーンスターチ配合外用医薬組成物
EP1354586A1 (en) * 2002-04-20 2003-10-22 Aventis Pharma Deutschland GmbH The use of hydroxpyridone-derivatives in wound healing
US20060257439A1 (en) * 2005-03-29 2006-11-16 Sabnis Ram W Cleansing compositions with color changing indicator
RU2326665C1 (ru) * 2007-04-03 2008-06-20 Марвел ЛайфСайнсез Лимитед, Великобритания Средство, обладающее противогипоксическим, противоинсультным, улучшающим память действием
US9090467B2 (en) * 2010-07-27 2015-07-28 Clariant Finance (Bvi) Limited Method of stabilizing hydrogen peroxide or hydrogen peroxide donor substances with hydroxypyridones or salts therof
US11110121B2 (en) * 2010-07-27 2021-09-07 Clariant International Ltd. Compositions comprising hydrogen peroxide or hydrogen peroxide donor substances
EA201792226A1 (ru) 2015-04-06 2018-08-31 САБДОМЭН, ЭлЭлСи Полипептиды, содержащие de novo связывающий домен, и их применение

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2540218A (en) 1947-08-25 1951-02-06 Squibb & Sons Inc 2-hydroxy-pyridine-n-oxide and process for preparing same
EP0241918B1 (de) * 1986-04-18 1992-05-27 Hoechst Aktiengesellschaft 1-Hydroxy-2-pyridone, Verfahren zu ihrer Herstellung und Arzneimittel, die sie enthalten, sowie bei der Herstellung der 1-Hydroxy-2-pyridone gebildete Zwischenprodukte
JPS63264504A (ja) * 1987-04-17 1988-11-01 Shinto Paint Co Ltd 工業用防カビ組成物
US4956184A (en) * 1988-05-06 1990-09-11 Alcide Corporation Topical treatment of genital herpes lesions
CA2046801C (en) * 1990-08-07 2002-02-26 Peter D. Davis Substituted pyrroles
DE4333893A1 (de) 1993-10-05 1995-04-06 Hoechst Ag Kosmetische Zubereitungen
AU7695596A (en) 1995-12-04 1997-06-27 Hoechst Aktiengesellschaft Use of 1-hydroxy-2-pyridones for treating mucosa diseases which are difficult to treat

Also Published As

Publication number Publication date
NZ505898A (en) 2002-06-28
ES2285829T3 (es) 2007-11-16
BR9907734A (pt) 2000-10-17
CN1128619C (zh) 2003-11-26
DE59914312D1 (de) 2007-06-06
EP1049468A1 (de) 2000-11-08
PL342055A1 (en) 2001-05-21
HUP0200851A1 (hu) 2002-07-29
DE19802708A1 (de) 1999-07-29
JP5127091B2 (ja) 2013-01-23
SK285350B6 (sk) 2006-11-03
HU228824B1 (en) 2013-05-28
MEP55908A (en) 2011-05-10
DK1049468T3 (da) 2007-07-30
AU2278799A (en) 1999-08-09
KR20010034325A (ko) 2001-04-25
PT1049468E (pt) 2007-05-31
JP2002501020A (ja) 2002-01-15
RU2212239C2 (ru) 2003-09-20
EP1049468B1 (de) 2007-04-25
KR100597332B1 (ko) 2006-07-10
YU43700A (sh) 2003-08-29
SI1049468T1 (sl) 2007-08-31
PL192550B1 (pl) 2006-11-30
HUP0200851A3 (en) 2003-05-28
IL137453A0 (en) 2001-07-24
CA2319359A1 (en) 1999-07-29
US6534528B1 (en) 2003-03-18
ATE360418T1 (de) 2007-05-15
TR200002118T2 (tr) 2000-12-21
CN1288380A (zh) 2001-03-21
CY1106684T1 (el) 2012-05-23
SK10892000A3 (sk) 2000-12-11
HK1034447A1 (en) 2001-10-26
RS50903B (sr) 2010-08-31
AU752406B2 (en) 2002-09-19
AR016445A1 (es) 2001-07-04
HRP20000496A2 (en) 2000-12-31
CA2319359C (en) 2008-03-18
ME00390B (me) 2011-05-10
WO1999037300A1 (de) 1999-07-29

Similar Documents

Publication Publication Date Title
IL174732A0 (en) Use of crystal modification of a n-phenyl-2-pyrimidineamine derivative in the preparation of a medicament for the treatment of restenosis
HU913776D0 (en) Process for the production of heparosane-n,o-sulphates, and medical preparations containing them as active agents
AU6897198A (en) Use of chondroitinase in the manufacture of a medicament in the treatment and prevention of mucoid secretions
HU9201937D0 (en) Aryl ethers, process for their production, and for the production of medical preparations containing them as active agents
HU911443D0 (en) Process for the production of medical preparations containing pravastaine and fibrinous-acid derivatives
EP0575749A3 (en) Use of potassium-channel activators for the manufacture of a medicament for the treatment of gastrointertinal ulcers
HU913450D0 (en) Process for the production of cyclopeptides and medical preparations containing them
HU914060D0 (en) Medical preparation and process for its production
AU4477893A (en) Use of C1-inactivator for the production of a pharmaceutical for the prophylaxis and therapy of certain diseases
GB9226832D0 (en) Pharmaceutical preparations for the treatment of psoriasis
EP0406178A3 (en) A wheeled stretcher for the easy transfer of patients from bed to stretcher and vice versa
IL137453A (en) Utilization of powder preparations containing hydroxypyridones for the production of a medicament for the treatment of leg ulcers and decubitus ulcers
HU913722D0 (en) The use of xantine derivatives for the production of medical preparations for preventing reactions after implantations
AU2314888A (en) Couch for care of the sick and elderly
HU9201358D0 (en) 2-amino-pirimidine-4-carboxamide derivatives, process for their production and for the production of medical preparations containing them as active agents
EP1224937A4 (en) STABLE PREPARATIONS FOR THE TREATMENT OF SIBS, SKIN ULCERS AND INJURIES
ZA975168B (en) Devices intended for the transdermic administration of trimegestone their preparation process and their use as medicaments
HU913654D0 (en) Process for the production of new amino-diol-derivatives and medical preparations containing them
HU912213D0 (en) Process for the production of amino-diol derivatives and medical preparations containing them
AU3691497A (en) A medicine of external use for treating seborrheic baldness with high efficacy and low side effect and preparation thereof
HU910109D0 (en) Process for the production of medical preparations for preventing proline-and lysine-hydroxylase and process for the production of some of the active agents
AU7057691A (en) Piperazine compound, production thereof, and medicinal use thereof
HU9200230D0 (en) Process for the production of 3-amino-sidnonimine derivatives and medical preparations containing them
AU3845489A (en) Wheel-chair for lifting and transporting patients that are unable to move
HU913159D0 (en) Process for the production of 3-piperazino-sydnonymine derivatives and medical preparations containing them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired